Form 13-F position report

STANDARD BIOTOOLS INC. COMMON

Reported by RENAISSANCE TECHNOLOGIES LLC

LAB CUSIP 34385P108 Manager CIK 0001037389

Reported 231,900 shares, up 114,400 (97.4%) from the prior quarter.

Reported value -12.1%; share count 97.4% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q2 2022
Shares 231,900 Quarter-end amount reported
Reported value $371,000 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 69000
2022-03-31 422000
2022-06-30 371000
2022-09-30 379000
2022-12-31 351000
2023-03-31 656000
2023-06-30 1207000
2023-09-30 1779000
2023-12-31 2298000
2024-03-31 3398000
2024-06-30 1778068
2024-09-30 387930
2024-12-31 0
2026-06-30 816166

Quarterly position history

How this manager's reported quarter-end position changed over time.

14 quarters
Quarterly reported position history for STANDARD BIOTOOLS INC. COMMON held by RENAISSANCE TECHNOLOGIES LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 New 992,058 +992,058 (0.0%) < 0.01% $816,166 2026-08-13
Q4 2024 Reduced 0 -201,000 (-100.0%) 0 $0 2025-02-13
Q3 2024 Reduced 201,000 -803,558 (-80.0%) < 0.01% $387,930 2024-11-13
Q2 2024 Reduced 1,004,558 -249,300 (-19.9%) < 0.01% $1,778,068 2024-08-09
Q1 2024 Added 1,253,858 +214,258 (20.6%) < 0.01% $3,398,000 2024-05-13
Q4 2023 Added 1,039,600 +426,200 (69.5%) < 0.01% $2,298,000 2024-02-13
Q3 2023 Reduced 613,400 -11,909 (-1.9%) < 0.01% $1,779,000 2023-11-14
Q2 2023 Added 625,309 +289,009 (85.9%) < 0.01% $1,207,000 2023-08-11
Q1 2023 Added 336,300 +36,200 (12.1%) < 0.01% $656,000 2023-05-12
Q4 2022 Reduced 300,100 -44,000 (-12.8%) < 0.01% $351,000 2023-02-13
Q3 2022 Added 344,100 +112,200 (48.4%) < 0.01% $379,000 2022-11-14
Q2 2022 Added 231,900 +114,400 (97.4%) < 0.01% $371,000 2022-08-12
Q1 2022 Added 117,500 +100,000 (571.4%) < 0.01% $422,000 2022-05-13
Q4 2021 New 17,500 +17,500 (0.0%) < 0.01% $69,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

124 managers reported STANDARD BIOTOOLS INC. COMMON for Q2 2022.

Managers reporting STANDARD BIOTOOLS INC. COMMON in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Indaba Capital Management L P Unchanged 7,446,229 0 1.57% $11,914,000 12 qtrs
PRIMECAP MANAGEMENT CO CA Reduced 4,955,343 -69,730 < 0.01% $7,929,000 37 qtrs
Neuberger Berman Group LLC Added 3,967,067 +15,072 < 0.01% $6,350,000 28 qtrs
NEEDHAM INVESTMENT MANAGEMENT LLC Added 3,873,903 +95,565 1.16% $6,198,000 9 qtrs
VANGUARD GROUP INC Reduced 3,557,554 -359,278 < 0.01% $5,692,000 37 qtrs
MORGAN STANLEY Added 3,101,305 +141,528 < 0.01% $4,960,000 37 qtrs
BOOTHBAY FUND MANAGEMENT LLC Added 2,321,122 +18,844 0.1% $3,714,000 6 qtrs
BlackRock Inc Reduced 2,017,210 -4,148,506 < 0.01% $3,228,000 37 qtrs
RA CAPITAL MANAGEMENT L P New 1,987,589 +1,987,589 0.08% $3,180,000 1 qtr
MILLENNIUM MANAGEMENT LLC Added 1,354,322 +659,831 < 0.01% $2,167,000 37 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 12, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
231,900
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.